|
|
|
Volumn 29, Issue 1, 1997, Pages 7-10
|
|
FACTOR AF2 as an adjuvant measure during chemotherapy - Myeloprotective and antiemetic effects;FACTOR AF2 als Begleitmassnahme zur Chemotherapie - Myeloprotektive und antiemetische Wirkungen
|
|
Author keywords
consumption of antiemetics; FACTOR AF2; leukopenia; quality of life; therapy observation; treatment cost saving
|
|
Indexed keywords
ANTIEMETIC AGENT;
ANTINEOPLASTIC AGENT;
BIOLOGICAL RESPONSE MODIFIER;
CYCLOPHOSPHAMIDE;
EPIRUBICIN;
FACTOR AF2;
FLUOROURACIL;
FOLINIC ACID;
ADULT;
AGED;
ARTICLE;
BONE MARROW SUPPRESSION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
GYNECOLOGIC CANCER;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
SUBCUTANEOUS DRUG ADMINISTRATION;
VOMITING;
|
|
EID: 0030936793
PISSN: 14322919
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (12)
|
